162 related articles for article (PubMed ID: 26919443)
21.
Malgundkar SH; Burney I; Al Moundhri M; Al Kalbani M; Lakhtakia R; Okamoto A; Tamimi Y
Genet Test Mol Biomarkers; 2021 Mar; 25(3):179-186. PubMed ID: 33734894
[No Abstract] [Full Text] [Related]
22. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
23. Hsa-miR-5582-3P regulatory effect on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3, and SMAD4 transcripts.
Abedini Bakhshmand E; Mohammad Soltani B; Fasihi A; Mowla SJ
J Cell Biochem; 2018 Dec; 119(12):9921-9930. PubMed ID: 30129155
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of E2F5 induces cell death via the TP53‑dependent pathway in breast cancer cells carrying wild‑type TP53.
Inagaki Y; Wu D; Fujiwara K; Ishizuka Y; Oguni A; Tokunaga T; Takayama T; Soma M; Fukuda N; Ozaki T; Masuda S
Oncol Rep; 2020 Nov; 44(5):2241-2252. PubMed ID: 33000282
[TBL] [Abstract][Full Text] [Related]
25. Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism.
Mirzoeva S; Franzen CA; Pelling JC
Mol Carcinog; 2014 Aug; 53(8):598-609. PubMed ID: 23359392
[TBL] [Abstract][Full Text] [Related]
26. Activation of transforming growth factor-beta1/p38/Smad3 signaling in stromal cells requires reactive oxygen species-mediated MMP-2 activity during bone marrow damage.
Wang L; Clutter S; Benincosa J; Fortney J; Gibson LF
Stem Cells; 2005 Sep; 23(8):1122-34. PubMed ID: 16002781
[TBL] [Abstract][Full Text] [Related]
27. Analysis of genetic aberrations on chromosomal region 8q21-24 identifies E2F5 as an oncogene with copy number gain in prostate cancer.
Zhao J; Wu XY; Ling XH; Lin ZY; Fu X; Deng YH; He HC; Zhong W
Med Oncol; 2013 Mar; 30(1):465. PubMed ID: 23377984
[TBL] [Abstract][Full Text] [Related]
28. Crosstalk between p38 and Smad3 through TGF-β1 in JEG-3 choriocarcinoma cells.
Xu Q; Tan Y; Zhang K; Li Y
Int J Oncol; 2013 Oct; 43(4):1187-93. PubMed ID: 23877620
[TBL] [Abstract][Full Text] [Related]
29. Sesamin inhibits lipopolysaccharide-induced proliferation and invasion through the p38-MAPK and NF-κB signaling pathways in prostate cancer cells.
Xu P; Cai F; Liu X; Guo L
Oncol Rep; 2015 Jun; 33(6):3117-23. PubMed ID: 25845399
[TBL] [Abstract][Full Text] [Related]
30. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
[TBL] [Abstract][Full Text] [Related]
31. [Effects of lncRNA SNHG12 on the proliferation, migration and invasiveness of prostate cancer cells by regulating E2F5 expression].
Xu SL; Gu XH; Feng Q
Zhonghua Nan Ke Xue; 2023 Feb; 29(2):113-119. PubMed ID: 37847082
[TBL] [Abstract][Full Text] [Related]
32. c-Ski inhibits the proliferation of vascular smooth muscle cells via suppressing Smad3 signaling but stimulating p38 pathway.
Li J; Li P; Zhang Y; Li GB; Zhou YG; Yang K; Dai SS
Cell Signal; 2013 Jan; 25(1):159-67. PubMed ID: 22986000
[TBL] [Abstract][Full Text] [Related]
33. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
Xu L; Chen S; Bergan RC
Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
35. Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells.
Buck MB; Pfizenmaier K; Knabbe C
Mol Endocrinol; 2004 Jul; 18(7):1643-57. PubMed ID: 15056732
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
37. miR-193b promotes cell proliferation by targeting Smad3 in human glioma.
Zhong Q; Wang T; Lu P; Zhang R; Zou J; Yuan S
J Neurosci Res; 2014 May; 92(5):619-26. PubMed ID: 24496888
[TBL] [Abstract][Full Text] [Related]
38. Involvement of Smad3 phosphoisoform-mediated signaling in the development of colonic cancer in IL-10-deficient mice.
Hachimine D; Uchida K; Asada M; Nishio A; Kawamata S; Sekimoto G; Murata M; Yamagata H; Yoshida K; Mori S; Tahashi Y; Matsuzaki K; Okazaki K
Int J Oncol; 2008 Jun; 32(6):1221-6. PubMed ID: 18497983
[TBL] [Abstract][Full Text] [Related]
39. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
[TBL] [Abstract][Full Text] [Related]
40. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.
Kang JM; Park S; Kim SJ; Hong HY; Jeong J; Kim HS; Kim SJ
Oncogene; 2012 Dec; 31(50):5123-31. PubMed ID: 22310290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
